3-Methylmethcathinone is a scheduled psychoactive compound whose CNS pharmacology involves potent modulation of dopamine, serotonin, and norepinephrine transporter systems, producing profound effects on mood, cognition, perception, and autonomic function at low doses. The pharmacological potency of 3-Methylmethcathinone in central monoaminergic circuits, combined with its cardiovascular stimulant effects, forms the basis for pharmacologically-based OEL derivation rather than conventional NOAEL approaches.
Threshold of Toxicological Concern methodology provides a default PDE for 3-Methylmethcathinone when conventional toxicological data are insufficient for NOAEL-based derivation. Cramer class assignment follows the decision-tree algorithm: Class I structures with simple chemistry lacking reactive functional groups carry a TTC of 1800 µg/day; Class I
